Biotechnology Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors May 26, 2022
Health NEW DATA SHOWCASES HOW AMGEN IS ADVANCING ALL ANGLES OF CANCER CARE THROUGH INNOVATIVE ONCOLOGY PORTFOLIO AND PIPELINE AT ASCO 2022 May 26, 2022
Biotechnology SHAREHOLDER ALERT: Weiss Law Reminds BHVN, SWCH, Y, and PLAN Shareholders About Its Ongoing Investigations May 26, 2022
Health ROSEN, SKILLED INVESTOR COUNSEL, Encourages AbbVie Inc. Investors With Losses to Secure Counsel Before Important June 6 Deadline in Securities Class Action – ABBV May 26, 2022
Biotechnology The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of VLTA, SDIG and AXSM May 26, 2022
Biotechnology BridgeBio Pharma Presents Positive Phase 1 Data in Healthy Volunteers, Advancing Development of BBP-671 for Pantothenate Kinase-Associated Neurodegeneration (PKAN) and Organic Acidemias May 26, 2022
Biotechnology CLASS ACTION UPDATE for ABBV, AXSM and CDNA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders May 26, 2022
Search
Health
